Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

GMED PEER ANALYSIS

Globus Medical — metric-by-metric comparison with peers and the industry median

GMEDGlobus Medical

🇺🇸 USA · NYSE · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial Health
GMEDIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
GMED+40.8%COH-56.9%PHIA+24.9%SHL-22.5%4DX+1,741.7%
Year-to-Date (YTD)
GMED-9.7%COH-50.6%PHIA+10.2%SHL-19.6%4DX+12.5%
1-Year
Split-adjusted
GMED+40.8%PODD-46.3%PEN+28.2%MASI+8.8%BRKR+41.7%GKOS+48.5%
Year-to-Date (YTD)
GMED-9.7%PODD-43.2%PEN+2.4%MASI+38.4%BRKR+23.8%GKOS+33.4%

Key Metric Comparison

P/E

Lower is better
GMED18.57COH24.11PHIA24.62SHL18.924DX—Median 27.09

ROE

Higher is better
GMED13.3%COH18.1%PHIA8.4%SHL11.4%4DX—Median -8.6%

Net Margin

Higher is better
GMED18.9%COH14.6%PHIA5.5%SHL9.1%4DX-3,684.6%Median -5.7%

Revenue Growth

Higher is better
GMED23.5%COH2.0%PHIA-1.9%SHL-0.3%4DX-26.0%Median 7.4%

P/E

Lower is better
GMED18.57PODD37.45PEN73.59MASI124.05BRKR—GKOS—Median 27.09

ROE

Higher is better
GMED13.3%PODD23.0%PEN12.7%MASI8.8%BRKR-0.5%GKOS-26.4%Median -8.6%

Net Margin

Higher is better
GMED18.9%PODD10.4%PEN11.8%MASI4.9%BRKR-0.3%GKOS-34.3%Median -5.7%

Revenue Growth

Higher is better
GMED23.5%PODD31.9%PEN17.3%MASI-14.4%BRKR0.4%GKOS36.3%Median 7.4%

All Metrics

Valuation
MetricGMEDCOHPHIASHL4DXInd. Median
P/E18.57●24.1124.6218.92—27.09
P/B2.304.302.102.18-77.13●2.51
EV/EBITDA11.8015.1110.81●12.04—15.39
P/S3.513.531.35●1.72252.892.62
Financial Health
MetricGMEDCOHPHIASHL4DXInd. Median
Current Ratio4.562.461.321.106.57●3.28
Debt/Equity2.4%22.1%71.1%84.1%-22.6%●44.7%
NetDebt/EBITDA-0.58●0.422.033.040.710.82
Profitability
MetricGMEDCOHPHIASHL4DXInd. Median
Net Margin18.9%●14.6%5.5%9.1%-3,684.6%-5.7%
ROE13.3%18.1%●8.4%11.4%—-8.6%
ROA11.6%12.4%●3.6%4.6%-264.3%-6.4%
EBITDA Margin28.4%●24.0%15.4%19.1%-818.8%5.2%
Growth + Dividend
MetricGMEDCOHPHIASHL4DXInd. Median
Rev. Growth23.5%●2.0%-1.9%-0.3%-26.0%7.4%
NI Growth216.2%●-6.8%160.1%0.3%—16.7%
Div. Yield—3.6%●3.5%2.9%—1.1%
Payout—81.5%33.8%48.4%—39.0%
Valuation
MetricGMEDPODDPENMASIBRKRGKOSInd. Median
P/E18.57●37.4573.59124.05——27.09
P/B2.30●8.718.5412.003.6313.032.51
EV/EBITDA11.80●20.5456.8528.5234.47—15.39
P/S3.513.918.666.072.57●15.852.62
Financial Health
MetricGMEDPODDPENMASIBRKRGKOSInd. Median
Current Ratio4.562.496.02●2.681.555.433.28
Debt/Equity2.4%●72.8%14.7%61.6%68.2%15.4%44.7%
NetDebt/EBITDA-0.58●0.81-0.111.055.081.210.82
Profitability
MetricGMEDPODDPENMASIBRKRGKOSInd. Median
Net Margin18.9%●10.4%11.8%4.9%-0.3%-34.3%-5.7%
ROE13.3%23.0%●12.7%8.8%-0.5%-26.4%-8.6%
ROA11.6%●9.3%9.8%3.9%-0.2%-20.4%-6.4%
EBITDA Margin28.4%●19.8%15.2%22.1%8.8%-26.1%5.2%
Growth + Dividend
MetricGMEDPODDPENMASIBRKRGKOSInd. Median
Rev. Growth23.5%31.9%17.3%-14.4%0.4%36.3%●7.4%
NI Growth216.2%-24.7%305.0%●———16.7%
Div. Yield————0.3%—1.1%
Payout————-377.6%—39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on GMED

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.